Geron Presents Interim Clinical Data on Its Telomerase Inhibitor Drug at AACR-NCI-EORTC (Business...
MENLO PARK, Calif.----Geron Corporation today announced the presentation of interim data from its ongoing trial of imetelstat , a telomerase inhibitor drug, in patients with refractory, advanced solid cancers at the 2009...



